EVAg

Receptor-binding domain aa 319 - 519 of SARS-CoV-2 (Wuhan), expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Beta variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutations K417N, E484K, N501Y. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus

Recombinant receptor binding domain (aa 319-591) of SARS-CoV-2 Alpha variant (mutations: N501Y, A570D) , expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutations L452R and E484Q. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutation L452R. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutation T478K. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutation S477N. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutation E484Q. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutation E484K. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutations L452R and N501Y. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Variant of the SARS-CoV-2 receptor binding domain (aa 319-591) with mutations E484K and N501Y. Recombinant protein expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Recombinant receptor binding domain (aa 319-591) of SARS-CoV-2 Gamma variant (mutations: K417T, E484K, N501Y) , expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Recombinant receptor binding domain (aa 319-591) of SARS-CoV2 Omicron variant BA.1 (Mutations: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A,  Q493K, G496S, Q498R, N501Y, Y505H, T547K), expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Recombinant receptor binding domain (aa 319-591) of SARS-CoV2 Delta variant (mutations: L452R, T478K), expressed in Expi293 cells and Streptactin-purified. The protein is equipped with a SpyTag (AHIVMVDAYKPTK) at the C-terminus.

Recombinant humanized monoclonal antibody against Schmallenberg orthobunyavirus, Isotype IgG1 / Igƙ, fused to Venus fluorophore

Influenza-A-Virus (H1N1), isolate "A/swine/Bakum/5/95" (RVB-0330), 2000, Germany

anti-African swine fever virus (ASFV), clone 2E10B3

Pestivirus D (Border disease 4 Virus), strain "Isard (D46/06)" (RVB-0476), France 2006

Pestivirus D (Border disease 2 Virus), strain "St 1507" (RVB-0112), Germany 2007

Alphacoronavirus 1 (Transmissible gastroenteritis Virus, TGEV), strain "70" (RVB-1158), Germany 1980

Rotavirus A (G3P14I2, RV-A), strain "ALA" (RVB-1224), USA 1976

Cardiovirus A (Encephalomyocarditis virus 1, EMCV 1, RVB-0002), strain "LC 75 (Cuba)", Cuba 1982

Bovine mastadenovirus B (Bovine adenovirus 3), strain "WBR 1" (RVB-0004), 1989, Germany

Reverse genetics-based life cycle modelling system that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and Lloviu virus entry into target cells under BSL1 conditions.

Reverse genetics-based life cycle modelling system that can serve as negative control and is best used together with other trVLP systems that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and entry into target cells under BSL1 conditions.